V1RG1 activators comprise a diverse chemical class designed to regulate the activity of the V1RG1 receptor, a specific type of G protein-coupled receptor (GPCR) found in the vomeronasal organ of mammals. These activators can influence the receptor function by modulating the signaling pathways that the V1RG1 receptor is involved in. The mechanisms by which these activators work can vary, depending on their chemical nature and the target within the signaling cascade. Some activators operate by increasing the intracellular concentration of secondary messengers like cyclic AMP (cAMP), which play a crucial role in the signal transduction process that follows GPCR activation. Others can influence the activity of specific G proteins, either by enhancing their activation or by inhibiting their repressive effects on certain signaling pathways, thereby modulating the receptor's ability to initiate a cellular response.
The chemical class of V1RG1 activators includes compounds that act at different points in the signaling cascade, from the receptor level to various intracellular effectors and enzymes that shape the signaling output. These activators can alter the function of enzymes like adenylyl cyclase, which catalyzes the conversion of ATP to cAMP, or phospholipase C, which generates diacylglycerol and inositol triphosphate, both of which serve as secondary messengers. Similarly, some activators target protein kinases such as protein kinase A or C, which phosphorylate a myriad of cellular proteins, thus affecting the receptor's signaling efficacy and cellular responsiveness. By modulating these signaling components, V1RG1 activators can fine-tune the receptor's responses to its natural ligands, affecting the overall signaling dynamics within the vomeronasal cells. This modulation can influence the way animals perceive and respond to pheromones, which are the natural stimuli for these receptors.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Adenylyl cyclase activator that increases intracellular cAMP levels, which could possibly activate V1RG1-mediated signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inhibits Gi/o type G proteins, which could possibly activate V1RG1 by increasing the activity of other G protein pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activator of protein kinase C (PKC), could possibly activate V1RG1 by modulating GPCR desensitization and signaling pathways. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $120.00 $275.00 $380.00 $670.00 $1400.00 $3000.00 | 12 | |
Cholinergic agonist that could possibly activate V1RG1 by modulating muscarinic GPCR signaling in cells. | ||||||
KI 8751 | 228559-41-9 | sc-203090 | 5 mg | $139.00 | 2 | |
Specific inhibitor of Gq protein, could possibly activate V1RG1 by modulating GPCR signaling involving Gq proteins. |